Pharmena S.A. (WSE:PHR)
3.320
-0.100 (-2.92%)
Apr 28, 2026, 2:01 PM CET
Pharmena Market Cap
Pharmena has a market cap or net worth of 36.98 million as of April 28, 2026. Its market cap has decreased by -19.42% in one year.
Market Cap
36.98M
Enterprise Value
29.61M
Revenue
1.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.32
Market Cap Chart
Since August 25, 2008, Pharmena's market cap has decreased from 171.99M to 36.98M, a decrease of -78.50%. That is a compound annual growth rate of -8.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 38.09M | 31.54% |
| Dec 30, 2025 | 28.96M | -32.11% |
| Dec 30, 2024 | 42.66M | -46.06% |
| Dec 29, 2023 | 79.08M | 26.79% |
| Dec 30, 2022 | 62.37M | -29.20% |
| Dec 30, 2021 | 88.10M | -10.89% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ryvu Therapeutics | 553.73M |
| Captor Therapeutics Spolka Akcyjna | 508.27M |
| Bioceltix | 408.24M |
| BIOTON | 359.34M |
| Synthaverse | 236.37M |
| Mabion | 133.82M |
| Molecure | 118.06M |
| NanoGroup | 108.06M |